Whether it is APP or one of its breakdown products that causes this increased neuronal activity and seizure phenotype in genetic mouse models of AD is still subject to debate, although the main suspect is Aβ (Vogt et al., 2011; Born et al., 2014; Mensch et al., 2021). The gene discussed is APP; the disease is Alzheimer disease.